【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Iressa
04.1.2 Abraxane
04.1.3 Alimta
04.1.4 Gemzar
04.1.5 Xalkori
04.1.6 Avastin
04.1.7 Tarceva
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.2 Economic Burden
07.3 Classification of Lung Cancer
07.4 Diagnosis
07.5 Small Cell Lung Cancer
07.5.1 Rate of Incidence and Prevalence
07.5.2 Staging
07.5.3 Management
07.6 Non-small Cell Lung Cancer
07.6.1 Rate of Incidence and Prevalence
07.6.2 Staging
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Disease Type
09.1 Global Non-small Cell Lung Cancer Therapeutics Market
09.1.1 Market Size and Forecast
09.1.2 Market Segmentation by Molecule Type
09.1.3 Market Segmentation by Routes of Administration
09.2 Global Small Cell Lung Cancer Therapeutics Market
09.2.1 Market Size and Forecast
10.Market Segmentation by Molecule Type
10.1 Biologics
10.2 Small Molecules
11.Market Segmentation by Route of Administration
11.1 Oral
11.2 Parenteral
12.Geographical Segmentation
12.1 Global Non-Small-Cell Lung Cancer Market
12.2 Global Small Cell Lung Cancer Market
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 AstraZeneca
20.2.2 Celgene
20.2.3 Eli Lilly
20.2.4 F. Hoffmann-La Roche
20.2.5 Pfizer
20.3 Other and Future Prominent Vendors
21.Pipeline Portfolio
21.1.1 Non-small Cell Lung Cancer
21.1.2 Small Cell Lung Cancer
22.Key Vendor Analysis
22.1 AstraZeneca
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
22.1.4 Business Strategy
22.1.5 Revenue by Business Segmentation
22.1.6 Revenue Comparison 2011-2013
22.1.7 Sales Revenue by Geographical Segmentation
22.1.8 Key Developments
22.1.9 SWOT Analysis
22.2 Celgene
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Strategy
22.2.4 Business Segmentation by Revenue
22.2.5 Sales by Geography
22.2.6 Key Information
22.2.7 SWOT Analysis
22.3 Eli Lilly
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation by Revenue
22.3.4 Sales by Geography
22.3.5 Business Strategy
22.3.6 Key Information
22.3.7 SWOT Analysis
22.4 F. Hoffmann-La Roche Ltd.
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Information
22.4.8 SWOT Analysis
22.5 Pfizer
22.5.1 Key Facts
22.5.2 Business Overview
22.5.3 Business Segmentation by Revenue 2013
22.5.4 Business Segmentation by Revenue 2012 and 2013
22.5.5 Geographical Segmentation by Revenue
22.5.6 Business Strategy
22.5.7 Key Developments
22.5.8 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Incidence Data of Lung Cancer pertaining to WHO Regions
Exhibit 3: Classification of Lung Cancer Types
Exhibit 4: Diagnosis of Lung Cancer in Patients
Exhibit 5: Staging of Small Cell Lung Cancer
Exhibit 6: Stepwise Diagrammatic Representation of the Management of Small Cell Lung Cancer According to the ESMO Guidelines
Exhibit 7: Types of Non-small Cell Lung Cancer
Exhibit 8: Percentage of Gene Mutations in Non-small Cell Lung Cancer
Exhibit 9: Staging of Non-small Cell Lung Cancer
Exhibit 10: Global Lung Cancer Therapeutics Market 2014-2019 (US$ million)
Exhibit 11: Global Lung Cancer Therapeutics Market Segmentation by Disease Type
Exhibit 12: Global Lung Cancer Therapeutics Market Segmentation by Disease Type 2014
Exhibit 13: YoY Revenue Comparison of Global Non-small Cell Lung Cancer Therapeutics market and Global Small Cell Lung Cancer Therapeutics market 2014-2019 (US$ million)
Exhibit 14: Global Non-small Cell Lung Cancer Therapeutics Market 2014-2019 (US$ million)
Exhibit 15: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type
Exhibit 16: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type 2014
Exhibit 17: Global Non-Small-Cell Lung Cancer Market Segmentation by Route of Administration
Exhibit 18: Global Non-Small-Cell Lung Cancer Market Segmentation by Routes of Administration 2014
Exhibit 19: Global Small Cell Lung Cancer Therapeutics Market 2014-2019 (US$ million)
Exhibit 20: Global Lung Cancer Therapeutics Market Segmentation by Molecule Type
Exhibit 21: Global Lung Cancer Therapeutics Market Segmentation by Molecule Type 2014
Exhibit 22: Global Lung Cancer Therapeutics Market Segmentation by Route of Administration
Exhibit 23: Global Lung Cancer Therapeutics Market Segmentation by Route of Administration 2014
Exhibit 24: Global Lung Cancer Therapeutics Market by Geographical Segmentation 2014
Exhibit 25: Global Non-small Cell Lung Cancer Market by Geographical Segmentation 2014
Exhibit 26: Global Small Cell Lung Cancer Market by Geographical Segmentation 2014
Exhibit 27: Buying Criteria of Global Lung Cancer Therapeutics Market 2014
Exhibit 28: Drivers of the Global Lung Cancer Therapeutics Market
Exhibit 29: Challenges of the Global Lung Cancer Therapeutics Market
Exhibit 30: Trends of the Global Lung Cancer Therapeutics Market
Exhibit 31: Global Lung Cancer Therapeutics Market by Vendor Segmentation 2014
Exhibit 32: Global Non-Small-Cell Lung Cancer Market by Market Share Analysis 2014
Exhibit 33: Sales Comparison of Major Drugs 2010-2013 (US$ million)
Exhibit 34: Sales of Iressa 2006-2013 (US$ million)
Exhibit 35: Sales of Iressa in Western Europe 2009-2013 (US$ million)
Exhibit 36: Sales of Iressa in Established ROW 2009-2013 (US$ million)
Exhibit 37: Sales of Iressa in Emerging Markets 2009-2013 (US$ million)
Exhibit 38: Region-wise Sales of Iressa 2009-2011 (US$ million)
Exhibit 39: Sales of Abraxane 2010-2013 (US$ million)
Exhibit 40: Sales of Alimta in US 2004-2013 (US$ million)
Exhibit 41: Sales of Alimta Outside US 2004-2013 (US$ million)
Exhibit 42: Total Sales of Alimta 2004-2013 (US$ million)
Exhibit 43: Region-wise Sales of Alimta 2004-2013 (US$ million)
Exhibit 44: Sales of Gemzar in US 2003-2011 (US$ million)
Exhibit 45: Sales of Gemzar Outside US 2003-2011 (US$ million)
Exhibit 46: Total Sales of Gemzar 2003-2011 (US$ million)
Exhibit 47: Region-wise Sales Gemzar 2003-2011 (US$ million)
Exhibit 48: Sales of Avastin and Tarceva 2005-2013 (US$ million)
Exhibit 49: Sales of Avastin 2005-2013 (US$ million)
Exhibit 50: Sales of Tarceva 2005-2013 (US$ million)
Exhibit 51: Sales Forecast for Xalkori 2013-2018 (US$ million)
Exhibit 52: Phase III Pipeline Portfolio of Global Lung Cancer Therapeutics Market by Disease Type 2014
Exhibit 53: Late-stage Pipeline Molecules for Non-small Cell Lung Cancer
Exhibit 54: Late-stage Pipeline Molecules for Small Cell Lung Cancer
Exhibit 55: Study Count of Small Cell Lung Cancer Clinical Trials by Geography
Exhibit 56: Study Count of Non-small Cell Lung Cancer Clinical Trials by Geography
Exhibit 57: AstraZeneca: Business Segmentation
Exhibit 58: AstraZeneca: Revenue by Business Segmentation 2013
Exhibit 59: AstraZeneca: Revenue by Business Segmentation 2011-2013 (US$ billion)
Exhibit 60: AstraZeneca: Sales Revenue by Geographical Segmentation 2013
Exhibit 61: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 62: Celgene: Sales by Geography 2013
Exhibit 63: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 64: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 65: Eli Lilly: Sales by Geography 2013
Exhibit 66: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 67: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 68: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 69: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 70: Pfizer: Business Segmentation by Revenue 2013
Exhibit 71: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 72: Pfizer: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：肺がん治療薬の世界市場：非小細胞肺がん、小細胞肺がん■ 英文：Global Lung Cancer Therapeutics Market 2015-2019
■ 発行日：2014年11月26日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4668
■ 調査対象地域：グローバル
- エマージング非在来型エネルギー動向：政策環境、開発、課題Emerging Unconventional Resources Overview - Regulatory Environment, Industry Developments and Key Challenges Summary "Emerging Unconventional Resources Overview - Regulatory Environment, Industry Developments and Key Challenges" is the latest report from GlobalData, the oil and gas industry analysis specialist, to examine the emerging markets for the development of unconventional resources outsid …
- 世界の中小企業におけるパブリッククラウド市場（2012-2016）TechNavio's analysts forecast the Global Public Cloud market in Small and Medium-sized Businesses to grow at a CAGR of 24.6 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing popularity of SaaS services among SMBs. The Global Public Cloud market in Small and Medium-sized Businesses has also been witnessing the increasing adoption of publi …
- 基底細胞癌治療薬の世界市場2018-2022107pages, November 2018 About this market The advancements in the field of oncology research is expected to help the market grow during the forecast period. The key players in the market are constantly developing medicines for various cancer indications. Technavio’s analysts have predicted that the basal cell carcinoma therapeutics market will register a CAGR of around 6% by 2022. Market Overview …
- オプトエレクトロニクスの世界市場2017-2021：LED、光学アイソレータ、イメージセンサ、レーザダイオード、光スイッチAbout OptoelectronicsOptoelectronics is the study of combined technology of electronic device and light. It is a sub-field of photonics. The study includes visible light as well as X-rays, gamma rays, ultra-violet (UV) rays, and infrared (IR) rays. Optoelectronic devices act as optical-to-electrical or electrical-to-optical transducers. LED, image sensors, optical switches, laser diodes, and optic …
- Bill Barrett Corporation：石油・ガスバリューチェーン分析レポート2013Bill Barrett Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Bill Barrett Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Bill Barrett Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The …
- 緊張性頭痛(Tension -Type Headache)：世界の治験レビュー（2015年上半期版）Tension -Type Headache Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Tension -Type Headache Global Clinical Trials Review, H1, 2015" provides data on the Tension -Type Headache clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tension -Type Headache. It includes an overview of the trial numbers and …
- 世界の生体用金属市場2015The Global Biomedical Metal Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Biomedical Metal industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Biomedical Metal market analysis is provided for the international markets including development trends, …
- 食品サービスの世界市場予測・分析2020-2024Global Foodservice Market: About this market Technavio’s foodservice market analysis considers sales from conventional, centralized, ready-prepared, and assembly-serve foodservice systems. Our study also finds the sales of foodservice in APAC, Europe, MEA, North America, and South America. In 2019, the conventional segment had a significant market share, and this trend is expected to continue over …
- スポンジ及び研磨パッドの世界市場2017-2021About Sponge and Scouring PadsSponges are a soft and porous material made from foamed plastic polymers, which are used for delicate cleansing. Scouring pads are small pads made of plastic mesh or metal, which can be used to scour harsh surfaces. The scrubbers are cleaning tools that can be used to clean large areas. The sponges and scouring pads are cleaning tools used for cleansing various equipm …
- トルエンジイソシアネート（TDI）の世界市場This report covers the Global Toluene Diisocyanate Market. It further divides the market on the basis of applications and geographies. The market data for these applications is given with respect to volume (KT) and value (USD MN). The market value of toluene diisocyanate was estimated to be $ 6195.6 million in 2014 and is projected to grow with a CAGR of about 5.4% from 2014 to 2019. The data ment …
- 世界のAmino Acids市場動向（2012-2016）TechNavio’s analysts forecast the Global Amino Acids market to grow at a CAGR of 25.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for amino acid-based dietary supplements. The Global Amino Acids market has also been witnessing an increase in mergers and acquisitions. However, stringent government regulatory norms for the app …
- UV（紫外線）安定剤の世界市場：HALS（光安定剤）、UVA（紫外線吸収剤）、消光剤The global UV stabilizer market size, in terms of value, is projected to reach USD 324.4 Million by 2020, registering a CAGR of 6.7% between 2015 and 2020. The growing manufacturing industries, increasing demand for UV stabilizers in the Asia-Pacific region, increasing demand of wood coatings in North America, and continuous product development, expansion, and merger & acquisition activities under …
- インドの鉄鋼市場2016-2020About Steel Industry Steel is composed of iron, carbon, metal impurities, and alloying elements that determine its chemical and physical properties. Based on its properties, steel is classified into carbon steel, alloy steel, and stainless steel. It has numerous advantages such as strength, durability, corrosion resistance, hardening ability, formability, welding ability, and ductility. Technavio’ …
- 下大静脈（IVC）フィルターの世界市場2017-2021ABSTRACTAbout Inferior Vena Cava (IVC) Filter An IVC filter is a cone-shaped medical device that is implanted in the IVC, below the kidneys. This is designed to capture an embolism or a blood clot that has broken loose from one of the deep veins in the legs on its way to the heart and lungs. The global IVC filter market is segmented into retrievable and permanent IVC filters, based on the type of …
- POSレシートプリンターの世界市場2016-2020About POS Printer A PoS printer is primarily used to print and encode receipts at retail stores, and hotel and restaurants chains. There are two main types of PoS printers in the global market - impact and thermal. Technavio’s analysts forecast the global PoS printer market to grow at a CAGR of 7.77% during the period 2016-2020. [Covered in this report] The report covers the present scenario and t …
